The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
ArticleNo Access

TREATMENT OF THE ACUTE ALCOHOLIC WITH INJECTABLE THIORIDAZINE

Published Online:https://doi.org/10.1176/ajp.120.5.496

Thioridazine by deep intramuscular injection was found to be an effective preparation for the symtomatic treatment of patients with acute alcoholism. Relief of nervous tension and anxiety and lifting of depression brought about improved cooperation, largely because thioridazine did not induce sleep. The only side effect was a 20- 30 mm. Hg fall in systolic blood pressure in 3 patients, relieved by a reduction in the frequency of injections. These findings and the absence of extrapyramidal stimulation or hepatotoxicity warrant further study of injectable thioridazine in the treatment of acute alcoholism.

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.